Pabau GO app

The new Pabau GO is heredownload on the App Store

Download on the App Store
Book a demo Book a demo
Diagnostic Codes

ICD-10 Code M35.5: Multifocal fibrosclerosis coding guide

Key takeaways

Key takeaways

ICD-10 Code M35.5 is the billable diagnosis code for multifocal fibrosclerosis, a rare idiopathic fibrosing condition affecting multiple organ systems.

M35.5 is a specific, billable ICD-10-CM code valid for FY2026, effective October 1, 2025, and applicable for HIPAA-covered transactions.

Multifocal fibrosclerosis must be distinguished from IgG4-related disease during coding. The two conditions were historically conflated but differ histopathologically.

IgG4-related disease has its own billable ICD-10-CM code, D89.84, effective FY2026, and coders should use it instead of M35.5 once IgG4-RD is documented.

Practice management software like Pabau supports accurate ICD-10-CM documentation workflows, reducing coding errors for complex connective tissue diagnoses.

ICD-10 Code M35.5 is the billable ICD-10-CM diagnosis code for multifocal fibrosclerosis, a rare idiopathic condition where dense fibrous tissue proliferates across multiple organ systems. It sits in the M30-M36 block for systemic connective tissue disorders. Coders frequently confuse it with IgG4-related disease, since the two conditions were historically grouped together.

Knowing where M35.5 sits in the ICD-10-CM hierarchy, which synonyms it covers, and how it differs from related codes is what keeps claims clean. This guide covers code details, anatomical manifestations, the full M35 sibling-code table, the IgG4-RD differential, and the documentation requirements that determine whether M35.5 gets paid.

ICD-10 Code M35.5: Multifocal fibrosclerosis at a glance

The table below captures the key billing properties coders need before submitting a claim using M35.5. All details reflect the CMS ICD-10-CM FY2026 release.

Property Detail
Code M35.5
Full description Multifocal fibrosclerosis
Billable/specific Yes
Valid fiscal year FY2026
Effective date October 1, 2025
ICD-10-CM chapter M00-M99 (Musculoskeletal system and connective tissue)
Block M30-M36 (Systemic connective tissue disorders)
Category M35 (Other systemic involvement of connective tissue)
HIPAA-covered transactions Yes
POA exempt No (present-on-admission indicator required for inpatient)

What is multifocal fibrosclerosis?

Multifocal fibrosclerosis is a rare disorder in which dense fibrous tissue proliferates at multiple anatomical sites, progressively displacing normal structures. The cause is idiopathic in most cases, though an autoimmune or inflammatory mechanism is suspected. Fibrous infiltration can compress nearby organs, vessels, and ducts, producing organ-specific symptoms that vary widely between patients.

The condition affects the retroperitoneum most commonly, but it can involve the mediastinum, thyroid, orbit, and bile ducts simultaneously or in sequence. Because each affected site can mimic a site-specific disease, the systemic nature is often missed until multiple presentations accumulate. Rheumatologists and internists tend to hold this diagnosis; coders should expect it on complex multi-system records.

For practices running functional medicine software, accurate code capture matters. Multifocal fibrosclerosis is frequently undercoded because clinicians default to the organ-specific presentation, such as retroperitoneal fibrosis, rather than the systemic multifocal code.

  • Primary sites: retroperitoneal space, mediastinum, thyroid gland, orbit, bile ducts
  • Pathology: dense collagen deposition with lymphoplasmacytic infiltrate
  • Onset: insidious; often years between first symptom and systemic diagnosis
  • Population: predominantly middle-aged adults; slight male predominance in retroperitoneal presentations
  • Key distinction: idiopathic fibrosclerosis affecting multiple sites, not attributable to a single-organ disease or a recognized fibrosing systemic condition (like IgG4-RD)

Code classification: M35.5 within the ICD-10-CM hierarchy

ICD-10 Code M35.5 sits four levels deep in the ICD-10-CM hierarchy. Understanding the parent categories helps coders navigate the M35 range without selecting a more general code by mistake. The WHO ICD-10 browser and the CDC/NCHS ICD-10-CM web tool both display this hierarchy interactively.

Level Code range Description Billable?
Chapter M00-M99 Diseases of the musculoskeletal system and connective tissue No
Block M30-M36 Systemic connective tissue disorders No
Category M35 Other systemic involvement of connective tissue No
Code M35.5 Multifocal fibrosclerosis Yes

M35 as a category gathers connective tissue conditions that do not fit the more specific categories earlier in the M30-M36 block. M35.5 is one of the few codes in M35 that represents a named, clinically distinct syndrome rather than a residual “other” classification.

Coders should resist the temptation to default to M35.9 (systemic connective tissue disorder, unspecified) when M35.5 is supported by the documentation.

Approximate synonyms and alternate names for M35.5

ICD-10-CM accepts multiple clinical terms as synonymous with M35.5 for index-lookup and documentation purposes. Coders using the alphabetic index may encounter these phrases in clinical notes and should map them to M35.5 rather than searching for organ-specific codes. Many of these terms reflect the condition’s history under different nosological frameworks.

  • Multifocal fibrosclerosis (primary term)
  • Idiopathic fibrosclerosis
  • Systemic fibrosclerosis
  • Multifocal fibrosis
  • Fibrosclerosis, multifocal
  • Idiopathic multifocal fibrosclerosis
  • Systemic sclerosing syndrome (when multifocal presentation is documented)

When reviewing older records or referral letters, a phrase like “idiopathic fibrosclerosis involving retroperitoneum and mediastinum” maps directly to M35.5. The physician note does not need to use the term “multifocal fibrosclerosis” verbatim provided the documentation supports multifocal involvement. Coders familiar with how ICD-10-CM handles secondary manifestations of a systemic disease, such as N16, will recognize this index-first lookup pattern.

Anatomical sites involved in multifocal fibrosclerosis

M35.5 covers fibrosclerotic involvement at any combination of the recognized anatomical sites below. The diagnosis requires fibrous proliferation at more than one distinct site; single-site presentations warrant site-specific codes rather than M35.5. Each site below also has its own ICD-10-CM code, which may be assigned additionally when that manifestation requires separate clinical management.

Site Clinical presentation Site-specific code
Retroperitoneal space Ureteral obstruction, hydronephrosis, vascular encasement (Ormond’s disease) K68.2 (retroperitoneal fibrosis); N13.5 may be coded additionally for a ureteral obstruction or stricture
Mediastinum Superior vena cava syndrome, tracheal or bronchial compression J98.51 (mediastinitis)
Thyroid gland Woody-hard goiter, tracheal compression, hypothyroidism (Riedel thyroiditis) E06.5 (other chronic thyroiditis)
Orbit Proptosis, restricted eye movement, orbital pseudotumor appearance H05.119 (granuloma of orbit, unspecified side); a laterality digit is required for a complete code
Bile ducts Obstructive jaundice, cholangitis, biliary strictures K83.1 (obstruction of bile duct)

When two or more of these sites are documented, M35.5 becomes the principal systemic code. Site-specific codes may be assigned as additional codes when the organ manifestation independently drives the visit or procedure. Good structured patient records that capture multi-system involvement make this dual-coding straightforward at claim time.

Comprehensive patient records
Pabau’s patient records keep every fibrosclerotic site in one timeline, so coders can see the multi-site evidence M35.5 requires.

The M35 category covers a range of systemic connective tissue conditions that are not classified elsewhere in M30-M36. Selecting M35.5 specifically, rather than a neighboring code, requires documentation that supports multifocal fibrosclerotic involvement.

The table below lists the key M35 sibling codes with their descriptions and a practical note on when each applies. Cross-referencing against the AAPC ICD-10-CM code range can assist coders in confirming current code status.

Code Description Billable? When to use
M35.0x Sjögren syndrome (multiple subcodes by organ) Yes (subcodes) Documented Sjögren’s with specific organ involvement; use the relevant subcode, not M35.0x itself
M35.1 Other overlap syndromes Yes Mixed connective tissue disease; undifferentiated overlap not elsewhere classified
M35.2 Behcet’s disease Yes Behcet’s disease with systemic vasculitis; not a fibrosing condition
M35.3 Polymyalgia rheumatica Yes Proximal muscle pain and stiffness in older adults; elevated ESR/CRP
M35.4 Diffuse (eosinophilic) fasciitis Yes Shulman syndrome; fascial thickening with eosinophilia; distinct from fibrosclerosis
M35.6 Relapsing panniculitis [Weber-Christian] Yes Weber-Christian disease; relapsing febrile nodular panniculitis of subcutaneous fat; distinct from the fibrosing pattern in M35.5
M35.5 Multifocal fibrosclerosis Yes Idiopathic fibrosclerosis at two or more anatomical sites; ICD-10 Code M35.5 is the correct choice when multiple sites are documented
M35.7 Hypermobility syndrome Yes Joint hypermobility with musculoskeletal symptoms; no fibrosing component
M35.9 Systemic connective tissue disorder, unspecified Yes Last resort only; use when no more specific code in M35 is supported by documentation

Coders who regularly handle rheumatology records will find other ICD-10-CM musculoskeletal coding guides useful for comparison. M76.9 offers another example of how hierarchical code selection works in practice.

IgG4-related disease (IgG4-RD) is the most clinically significant differential diagnosis for multifocal fibrosclerosis. The two conditions were historically grouped together, and some older clinical notes will use the terms interchangeably. Modern histopathology distinguishes them clearly, but the coding implications only matter if the distinction is documented.

IgG4-RD now has its own dedicated, billable ICD-10-CM code: D89.84 (IgG4-related disease), effective FY2026. Older notes sometimes carry M35.00 (Sjogren syndrome, unspecified) or M35.8 (other specified systemic involvement of connective tissue). Coders used both as workarounds before the dedicated code existed.

Coders should now use D89.84 once IgG4-RD is documented, rather than defaulting to either substitute code. Coders should code what the physician documents rather than inferring the diagnosis. When the record explicitly states “IgG4-related disease,” M35.5 is not appropriate.

Feature Multifocal fibrosclerosis (M35.5) IgG4-related disease
Histopathology Dense fibrosis, lymphoplasmacytic infiltrate; no storiform fibrosis required Storiform fibrosis, obliterative phlebitis, elevated IgG4-positive plasma cells (>10/hpf)
Serology Normal IgG4 levels typically Elevated serum IgG4 in roughly 60-70% of cases (per rheumatology literature)
Response to steroids Variable Typically dramatic and rapid
Anatomical pattern Retroperitoneum, mediastinum, thyroid, orbit, bile ducts Similar multi-organ pattern; pancreas, salivary glands, and aorta more commonly involved
ICD-10-CM code M35.5 D89.84
Key documentation signal “Multifocal fibrosclerosis,” “idiopathic fibrosclerosis,” two or more fibrosclerotic sites “IgG4-related disease,” “IgG4-RD,” elevated IgG4 on biopsy or serum

The overlap matters clinically because coding M35.5 for a patient whose diagnosis is IgG4-RD can affect prior authorization decisions, treatment protocol approvals, and registry data. For coders managing records where the distinction is ambiguous, a physician query before claim submission is the correct approach.

Using HIPAA-compliant practice software that logs physician query workflows protects the practice if the coding decision is later reviewed.

Pro Tip

Run a quick chart review before submitting M35.5: confirm the note documents at least two distinct fibrosclerotic sites. A single-site presentation (retroperitoneal fibrosis alone, for example) should be coded to its own site-specific code, not to M35.5. Add the site-specific code as an additional code when the organ manifestation independently drives the encounter.

Coding guidelines and documentation requirements for ICD-10 Code M35.5

M35.5 follows standard ICD-10-CM coding conventions. The guidelines below reflect the CMS ICD-10-CM Official Guidelines for Coding and Reporting. Coders should verify requirements against the current fiscal year’s official guidelines, as these are updated annually.

  • Confirmed diagnosis required: M35.5 is a diagnostic code. Assign it only when the physician has documented multifocal fibrosclerosis as a confirmed diagnosis, not as a working hypothesis or rule-out.
  • First-listed vs. additional code: When multifocal fibrosclerosis is the reason for the encounter, M35.5 is the principal or first-listed code. When the visit addresses a specific organ complication, such as ureteral obstruction from retroperitoneal fibrosis, list that code first and add M35.5 second.
  • Dual coding for organ manifestations: Assign site-specific codes additionally when organ involvement independently affects clinical management. M35.5 plus K68.2 (retroperitoneal fibrosis) is an acceptable combination; N13.5 may be added separately if a ureteral complication is also documented.
  • HIPAA transaction eligibility: M35.5 is valid for all HIPAA-covered electronic transactions, including 837P (professional claims), 837I (institutional claims), and 837D (dental claims when applicable).
  • Present-on-admission (POA) indicator: Required for inpatient claims; document whether the fibrosclerosis was present at hospital admission.
  • ICD-10-CM Official Guidelines Section I.C.13: Musculoskeletal chapter guidelines apply. Code the condition to the highest level of specificity supported by documentation.

Practices managing rheumatology or multi-specialty connective tissue cases should build M35.5 documentation prompts into their intake and clinical note workflows. This reduces the likelihood of a vague “connective tissue disorder” note landing on a coder’s desk without the specificity needed to justify M35.5.

Diagnostic specificity matters just as much in code categories far removed from rheumatology. I34.9 shows the same principle at work in cardiac coding: a vague note forces a less specific, less useful code.

Practices that need to strengthen their documentation capture process can use digital intake forms that prompt for multi-system symptom history. This surfaces the multi-site involvement clinicians need to document before coding to M35.5. Combined with claims management software that flags under-specified diagnoses before submission, this reduces the risk of downcoding to M35.9.

Customizable consent and intake forms
Pabau’s digital intake forms prompt for symptoms across organ systems, flagging the multi-site pattern that supports an M35.5 diagnosis.

Code history: When did M35.5 become effective?

M35.5 has been part of ICD-10-CM since the system was adopted in the United States in October 2015. The code has remained stable, with no description changes or structural revisions in subsequent annual updates. For FY2026, it became effective on October 1, 2025.

Coders working with records dated before October 1, 2015 should note the predecessor ICD-9-CM code. Multifocal fibrosclerosis mapped to 710.8 (other specified diffuse diseases of connective tissue), a significantly less specific classification.

  • ICD-10-CM adoption (US): October 1, 2015
  • FY2026 effective date: October 1, 2025
  • Description changes since adoption: None
  • Prior ICD-9-CM equivalent: 710.8 (approximate; not a direct crosswalk)

Maintaining clinical documentation practices that track when diagnoses were established is especially useful for longitudinal connective tissue cases. The original diagnosis may predate the patient’s current practice relationship. Similarly, strong patient data security practices protect historical diagnosis records that span multiple fiscal years of ICD-10-CM updates.

How Pabau supports accurate coding for connective tissue diagnoses like M35.5

Rheumatology practices, osteopathic practices, and multi-specialty groups managing connective tissue diagnoses like M35.5 all face the same problem. The clinical note has to carry enough detail to support a specific code before it reaches a coder. When intake only captures a single organ complaint, the systemic pattern behind multifocal fibrosclerosis gets missed, and the claim defaults to a vaguer code.

Pabau’s digital intake forms prompt for symptom history across organ systems. A patient presenting with orbital swelling and a prior retroperitoneal complaint gets flagged for both, not coded to whichever complaint the front desk logs first.

That structured history carries straight into the patient’s record, so the clinician documenting the encounter already has the multi-site picture in front of them.

Claims management software then checks the coded diagnosis against the documentation on file before the claim goes out. This catches cases where a systemic code like M35.5 is supported but a coder has defaulted to a single-site alternative. For practices handling IgG4-RD alongside multifocal fibrosclerosis, the same workflow flags whether the note supports M35.5 or the dedicated D89.84 code.

Reduce coding errors on complex connective tissue diagnoses

Pabau's claims management software helps rheumatology and multi-specialty practices capture the diagnostic specificity that ICD-10 Code M35.5 and similar systemic codes require. See how structured documentation workflows reduce downcoding and claim rejections.

Pabau claims management and ICD-10 documentation workflow

Conclusion

Undercoding multifocal fibrosclerosis to a non-specific connective tissue code costs practices both accuracy and reimbursement. When documentation supports two or more fibrosclerotic sites, ICD-10 Code M35.5 is the correct, billable choice. With IgG4-RD now carrying its own code, D89.84, there’s no reason left to route that diagnosis through M35.5 or M35.8.

Getting the distinction right at the point of documentation, rather than catching it during a claims review, is what keeps reimbursement on schedule. Book a demo to see how Pabau supports accurate coding for connective tissue and multi-specialty diagnoses.

Continue your research

Continue your research

Coding a fracture complication with the same precision? S52.253K shows how ICD-10-CM captures a malunion with the same specificity multifocal fibrosclerosis coding demands.

Need another example of subsequent-encounter coding? S14.154D walks through documenting a subsequent encounter with the same level of specificity M35.5 requires.

Building documentation prompts for complex patients? A personal health plan template gives practices a structured way to capture multi-system history before it reaches a coder.

Frequently asked questions

What is ICD-10 Code M35.5?

ICD-10 Code M35.5 is the billable ICD-10-CM diagnosis code for multifocal fibrosclerosis, a rare idiopathic condition involving dense fibrous tissue proliferation at multiple anatomical sites. It falls under the M35 category (other systemic involvement of connective tissue) within the M30-M36 block of systemic connective tissue disorders.

Is M35.5 a billable ICD-10-CM code?

Yes. M35.5 is a specific, billable ICD-10-CM code valid for FY2026 and applicable for HIPAA-covered electronic transactions. It became effective October 1, 2025 and can be used as the principal or additional diagnosis code depending on the reason for the encounter.

What are the sites involved in multifocal fibrosclerosis?

The main anatomical sites are the retroperitoneal space (Ormond’s disease), mediastinum (sclerosing mediastinitis), thyroid gland (Riedel thyroiditis), orbit, and bile ducts. M35.5 applies when fibrosclerotic involvement is documented at two or more of these sites. Single-site presentations warrant the appropriate site-specific code instead.

What is the difference between M35.5 and IgG4-related disease?

IgG4-related disease is distinguished from multifocal fibrosclerosis by its histopathological hallmarks: storiform fibrosis, obliterative phlebitis, and elevated IgG4-positive plasma cells on biopsy. Normal serum IgG4 levels and the absence of these biopsy findings point toward multifocal fibrosclerosis. Clinicians and coders should not use M35.5 when the physician has documented IgG4-related disease; the dedicated code for that diagnosis is D89.84, effective FY2026.

What ICD-10-CM category does M35.5 fall under?

M35.5 falls under category M35 (other systemic involvement of connective tissue), within block M30-M36 (systemic connective tissue disorders). That block sits within chapter M00-M99, diseases of the musculoskeletal system and connective tissue. It is a leaf-level code with no further subcategory breakdowns.

When should a coder use M35.9 instead of M35.5?

M35.9 (systemic connective tissue disorder, unspecified) should only be used when documentation is insufficient to support any more specific M35 code. If the clinical note confirms multifocal fibrosclerotic involvement at two or more sites, M35.5 is the correct code. Default to M35.9 only as a last resort after exhausting physician query options.

What are the symptoms of multifocal fibrosclerosis?

Symptoms depend on which sites are involved. Retroperitoneal disease can cause ureteral obstruction and flank pain. Mediastinal involvement can compress the trachea and cause breathing difficulty. Thyroid involvement causes a hard, enlarged gland, and orbital involvement causes proptosis. Because onset is insidious, these symptoms often appear years apart rather than together.

How is multifocal fibrosclerosis treated?

Treatment usually starts with corticosteroids to slow the fibrous tissue growth, with other immunosuppressive agents added for relapsing or steroid-resistant cases. Site-specific procedures, such as ureteral stenting for retroperitoneal disease or a tracheal stent for mediastinal compression, address the local complication first. Response is more variable than in IgG4-related disease, which is one reason coders should confirm the correct diagnosis before choosing M35.5.

What ICD-10 code is used for IgG4-related disease?

IgG4-related disease has its own dedicated ICD-10-CM code, D89.84, effective FY2026. Coders should use D89.84 rather than M35.5 once a physician has documented IgG4-related disease. The two conditions require different codes despite their similar multi-organ pattern.

×